Abcellera Biologics inc

Abcellera Biologics Inc. is a biotechnology company based in Vancouver, Canada. The company specializes in the discovery of therapeutic antibodies using its proprietary AI-powered platform. Abcellera's platform is designed to rapidly screen and analyze millions of immune cells to identify the best antibodies for treating diseases such as cancer, infectious diseases, and autoimmune disorders. The company's technology has been used to identify antibodies for COVID-19 treatment, and it has partnered with pharmaceutical companies such as Eli Lilly and Company to develop and commercialize new therapies. Abcellera was founded in 2012 and has since grown to become one of the leading antibody discovery companies in the world.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.